Author/Editor     Maria, Bernard; Dublanchet, Alain; Strecker, Jurgen; Dennemark, Nils; Genazzani, Andrea; Fioretti, Piero; Schoon, Marthinus; Ponte, Conception; Fetih, Alenka; Hren-Vencelj, Helena
Title     Comparative evaluation of clindamycin/gentamicin and cefoxitin/doxycycline for treatment of pelvic inflammatory disease: a multi-center trial
Type     članek
Source     Acta Obstet Gynecol Scand
Vol. and No.     Letnik 71, št. 2
Publication year     1992
Volume     str. 129-34
Language     eng
Abstract     The clinical efficacy and safety of clindamycin-gentamicin versus doxycycline-cefoxitin in the treatment of acute pelvic inflammatory disease was evaluated in a comparative, randomized, prospective, multicenter study. Ten investigators enrolled 170 patients. Those judged to be eligible for efficacy were 60/88 (68 percent) who received the clindamycin-gentamicin regimen and 55/82 (67 percent) of those treated with cefoxitin-doxycycline. A successful clinical outcome was attained for 52/60 (87 percent) and 46/55 (84 percent) for patients treated with clindamycin-gentamicin and cefoxitin-doxycycline, respectively, a difference that was not statistically significant. In the clindamycin-gentamicin series, 8/8 (100 percent) of patients with positive C. trachomatis culture at baseline were culture negative at the late follow-up 21-35 days after treatment. For those given cefoxitin-doxycycline, 9/11 (82 percent) who had C. trachomatis at pretreatment showed eradication at follow-up. Neisseria gonorrhoeae was present at baseline in 8/60 (13 percent) of the clindamycin-gentamicin patients and in 9/55 (16 percent) of those treated with cefoxitin-doxycycline. Of those who had appropriate follow-up cultures performed, 6 in the clindamycin-gentamicin group and 8 in the cefoxitin-doxycycline series, all showed eradication of the organism. It is concluded that clindamycin-gentamicin and cefoxitin-doxycycline have similar clinical cure rates for acute pelvic inflammatory disease, and based on this limited experience, it is suggested that the clindamycin-gentamicin combination will satisfactorily eradicate Chlamydia trachomatis and Neisseria gonorrhoeae when either or both of these pathogens are present.
Descriptors     ADNEXITIS
CEFOXITIN
CLINDAMYCIN
DOXYCYCLINE
GENTAMICINS
ACUTE DISEASE
ADOLESCENCE
ADULT
ANTIBIOTICS, COMBINED
MIDDLE AGE
PROSPECTIVE STUDIES